Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Randomized Control Trial of Pre-Operative Low Molecular Weight Heparin Versus Tapered Warfarin as Bridging Therapy for Patients With Implantation of Pacemaker or Defibrillator

NCT02094157 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT02094157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02094157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Randomized Control Trial of Pre-Operative Low Molecular Weight Heparin Versus Tapered Warfarin as Bridging Therapy for Patients With Implantation of Pacemaker or Defibrillator
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2007
Completion date
March 31, 2014
Enrollment
173 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrhythmias, hemorrhage, thromboembolism